انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
‘First in Human’ Continuous Manufacturing in Biopharmaceuticals — A Conversation with Magnus Schroeder of Just – Evotec Biologics
Manage episode 454828412 series 3580470
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Magnus Schroeder, the VP, Process & Product Design for Just – Evotec Biologics, to talk about some of the advantages of continuous manufacturing in biopharmaceutical manufacturing, especially for companies whose products are approaching the First in Human (FIH) stage. It is never too early to think about process optimization, scalability, and controlling costs, but there is an understandable position where companies focused on the medicine and the science believe that can be sorted out later. Just – Evotec Biologics is a passionate advocate for taking lessons from other industries that build their businesses’ success into the R&D stage of their products’ development. So what does that look like in the Life Sciences? What role do CDMOs need to play to help the industry succeed at this, especially at the crucial FIH stage? For all this and more, give this episode a listen!
--
Magnus Schroeder
VP, Process & Product Design
Just – Evotec Biologics
--
Just – Evotec Biologics, wholly owned by Evotec SE, is a CDMO offering development and manufacturing services for antibody, next-generation biologics, and biosimilar products. We collaborate with partners starting from antibody discovery through process development and manufacturing with sites in US and Europe. We designed our technologies to reduce cost of goods and help expand global access to affordable high-quality biotherapeutics. Our team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics.
262 حلقات
Manage episode 454828412 series 3580470
At the 2024 edition of the Biomanufacturing World Summit series we sat down with Magnus Schroeder, the VP, Process & Product Design for Just – Evotec Biologics, to talk about some of the advantages of continuous manufacturing in biopharmaceutical manufacturing, especially for companies whose products are approaching the First in Human (FIH) stage. It is never too early to think about process optimization, scalability, and controlling costs, but there is an understandable position where companies focused on the medicine and the science believe that can be sorted out later. Just – Evotec Biologics is a passionate advocate for taking lessons from other industries that build their businesses’ success into the R&D stage of their products’ development. So what does that look like in the Life Sciences? What role do CDMOs need to play to help the industry succeed at this, especially at the crucial FIH stage? For all this and more, give this episode a listen!
--
Magnus Schroeder
VP, Process & Product Design
Just – Evotec Biologics
--
Just – Evotec Biologics, wholly owned by Evotec SE, is a CDMO offering development and manufacturing services for antibody, next-generation biologics, and biosimilar products. We collaborate with partners starting from antibody discovery through process development and manufacturing with sites in US and Europe. We designed our technologies to reduce cost of goods and help expand global access to affordable high-quality biotherapeutics. Our team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics.
262 حلقات
كل الحلقات
×
1 Renewable Raw Materials: BASF's Exciting Sustainability Initiatives 39:01

1 How Medical Device Companies and CDMOs are Partnering Together to Drive Innovation and Serve Patients Better 21:12

1 The Ctrl-Alt-Speech Podcast — A Conversation with Mike Masnick and Ben Whitelaw 38:03

1 Where Cell and Gene Therapies are Going — A Conversation with Diluks De Silva of Compliance Architects 14:47

1 Hari Pujar of Tessera Therapeutics & Flagship Pioneering — The Future of Medicine 15:40

1 Martin Müller & Søren Thuesen Pedersen of Novo Nordisk — Collaboration Among Industry Peers to Move the Life Sciences Forward 24:05

1 The Speaker Roundtable from BMWS24 — A Conversation About Biopharmaceutical Manufacturing Issues and Ideas 1:05:55

1 AI in Supply Chains: Today's Real-World Applications and What is Still to Come — A Conversation with Experts from Ernst & Young LLP 18:46

1 How CDMOs are Contributing to the Ongoing Future of Medicine — A Conversation with Nick Maragos of Northway Biotech 11:57

1 ‘First in Human’ Continuous Manufacturing in Biopharmaceuticals — A Conversation with Magnus Schroeder of Just – Evotec Biologics 10:52

1 John H. Adams, Jr. of Spark Therapeutics — Computer Software Assurance for Biopharmaceutical Manufacturers 14:33

1 The TechOps Leadership Accelerator Program — A Conversation with Pascal Bécotte and Laurent Rossi 21:49

1 How Technology Fits into the Larger Conversation of Change in the Manufacturing Sector — A Conversation with Sathish Thirmoorthy of UCBOS 14:19

1 The Speaker Roundtable from NAFMS24 — A Conversation About Food Manufacturing Issues and Ideas 49:12

1 AI’s Place in the Future of the Food and Beverage Industry’s Supply Chain and Manufacturing Operations — A Conversation with Jeremy Tancredi and Randal Kenworthy of West Monroe 29:01
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.